Genetic Predisposition for Renal Dysfunction and Incidence of CKD in the Malmö Diet and Cancer Study

Background: Genome-wide association studies (GWAS) have identified >50 single nucleotide polymorphisms (SNP) in association with estimated glomerular filtration rate (eGFR) and chronic kidney disease (CKD) but little is known about whether the combination of these SNPs may aid in prediction of fu...

Full description

Bibliographic Details
Main Authors: Christina-Alexandra Schulz, Gunnar Engström, Anders Christensson, Peter M. Nilsson, Olle Melander, Marju Orho-Melander
Format: Article
Language:English
Published: Elsevier 2019-08-01
Series:Kidney International Reports
Online Access:http://www.sciencedirect.com/science/article/pii/S2468024919301846
id doaj-54deac374fc94a15b1955fae16a7ceda
record_format Article
spelling doaj-54deac374fc94a15b1955fae16a7ceda2020-11-24T21:54:35ZengElsevierKidney International Reports2468-02492019-08-014811431151Genetic Predisposition for Renal Dysfunction and Incidence of CKD in the Malmö Diet and Cancer StudyChristina-Alexandra Schulz0Gunnar Engström1Anders Christensson2Peter M. Nilsson3Olle Melander4Marju Orho-Melander5Department of Clinical Sciences, Lund University, Malmö, SwedenDepartment of Clinical Sciences, Lund University, Malmö, SwedenDepartment of Nephrology, Lund University, Malmo, SwedenDepartment of Clinical Sciences, Lund University, Malmö, SwedenDepartment of Clinical Sciences, Lund University, Malmö, SwedenDepartment of Clinical Sciences, Lund University, Malmö, Sweden; Correspondence: Marju Orho-Melander, Department of Clinical Sciences, Malmö, CRC, Skåne University Hospital, Jan Waldenströms gata 35, SE 205 02 Malmö, Sweden.Background: Genome-wide association studies (GWAS) have identified >50 single nucleotide polymorphisms (SNP) in association with estimated glomerular filtration rate (eGFR) and chronic kidney disease (CKD) but little is known about whether the combination of these SNPs may aid in prediction of future incidence of CKD in the population. Methods: We included 2301 participants with baseline eGFR ≥60 mL/min per 1.73 m2 from the Malmö Diet and Cancer Study–Cardiovascular Cohort. The eGFR was estimated during baseline (1991–1996) and after a mean follow-up of 16.6 years using the CKD–Epidemiology Collaboration 2009 creatinine equation. We combined 53 SNPs into a genetic risk score weighted by the effect size (wGRSCKD), and examined its association with incidence of CKD stage 3A (eGFR ≤60 mL/min per 1.73 m2). Results: At follow-up, 453 study participants were defined as having CKD stage 3A. We observed a strong association between wGRSCKD and eGFR at baseline (P = 6.5 × 10−8) and at the follow-up reexamination (P = 5.0 × 10−10). The odds ratio (OR) for incidence of CKD stage 3A was 1.25 per 1 SD increment in the wGRSCKD (95% confidence interval [CI]: 1.12–1.39) adjusting for potential confounders (sex, age, body mass index [BMI], baseline eGFR, fasting glucose, systolic blood pressure (SBP), antihypertensive treatment, smoking, follow-up time). Adding wGRSCKD on the top of traditional risk factors did not improve the C-statistics (P = 0.12), but the Net Reclassification-Improvement-Index was significantly improved (cNRI = 21.3%; 95% CI: 21.2–21.4; P < 0.0001). Conclusion: wGRSCKD was associated with a 25% increased incidence of CKD per 1 SD increment. Although the wGRSCKD did not improve the prediction model beyond clinical risk factors per se, the information of genetic predisposition may aid in reclassification of individuals into correct risk direction. Keywords: CKD, eGFR, GRS, renal functionhttp://www.sciencedirect.com/science/article/pii/S2468024919301846
collection DOAJ
language English
format Article
sources DOAJ
author Christina-Alexandra Schulz
Gunnar Engström
Anders Christensson
Peter M. Nilsson
Olle Melander
Marju Orho-Melander
spellingShingle Christina-Alexandra Schulz
Gunnar Engström
Anders Christensson
Peter M. Nilsson
Olle Melander
Marju Orho-Melander
Genetic Predisposition for Renal Dysfunction and Incidence of CKD in the Malmö Diet and Cancer Study
Kidney International Reports
author_facet Christina-Alexandra Schulz
Gunnar Engström
Anders Christensson
Peter M. Nilsson
Olle Melander
Marju Orho-Melander
author_sort Christina-Alexandra Schulz
title Genetic Predisposition for Renal Dysfunction and Incidence of CKD in the Malmö Diet and Cancer Study
title_short Genetic Predisposition for Renal Dysfunction and Incidence of CKD in the Malmö Diet and Cancer Study
title_full Genetic Predisposition for Renal Dysfunction and Incidence of CKD in the Malmö Diet and Cancer Study
title_fullStr Genetic Predisposition for Renal Dysfunction and Incidence of CKD in the Malmö Diet and Cancer Study
title_full_unstemmed Genetic Predisposition for Renal Dysfunction and Incidence of CKD in the Malmö Diet and Cancer Study
title_sort genetic predisposition for renal dysfunction and incidence of ckd in the malmö diet and cancer study
publisher Elsevier
series Kidney International Reports
issn 2468-0249
publishDate 2019-08-01
description Background: Genome-wide association studies (GWAS) have identified >50 single nucleotide polymorphisms (SNP) in association with estimated glomerular filtration rate (eGFR) and chronic kidney disease (CKD) but little is known about whether the combination of these SNPs may aid in prediction of future incidence of CKD in the population. Methods: We included 2301 participants with baseline eGFR ≥60 mL/min per 1.73 m2 from the Malmö Diet and Cancer Study–Cardiovascular Cohort. The eGFR was estimated during baseline (1991–1996) and after a mean follow-up of 16.6 years using the CKD–Epidemiology Collaboration 2009 creatinine equation. We combined 53 SNPs into a genetic risk score weighted by the effect size (wGRSCKD), and examined its association with incidence of CKD stage 3A (eGFR ≤60 mL/min per 1.73 m2). Results: At follow-up, 453 study participants were defined as having CKD stage 3A. We observed a strong association between wGRSCKD and eGFR at baseline (P = 6.5 × 10−8) and at the follow-up reexamination (P = 5.0 × 10−10). The odds ratio (OR) for incidence of CKD stage 3A was 1.25 per 1 SD increment in the wGRSCKD (95% confidence interval [CI]: 1.12–1.39) adjusting for potential confounders (sex, age, body mass index [BMI], baseline eGFR, fasting glucose, systolic blood pressure (SBP), antihypertensive treatment, smoking, follow-up time). Adding wGRSCKD on the top of traditional risk factors did not improve the C-statistics (P = 0.12), but the Net Reclassification-Improvement-Index was significantly improved (cNRI = 21.3%; 95% CI: 21.2–21.4; P < 0.0001). Conclusion: wGRSCKD was associated with a 25% increased incidence of CKD per 1 SD increment. Although the wGRSCKD did not improve the prediction model beyond clinical risk factors per se, the information of genetic predisposition may aid in reclassification of individuals into correct risk direction. Keywords: CKD, eGFR, GRS, renal function
url http://www.sciencedirect.com/science/article/pii/S2468024919301846
work_keys_str_mv AT christinaalexandraschulz geneticpredispositionforrenaldysfunctionandincidenceofckdinthemalmodietandcancerstudy
AT gunnarengstrom geneticpredispositionforrenaldysfunctionandincidenceofckdinthemalmodietandcancerstudy
AT anderschristensson geneticpredispositionforrenaldysfunctionandincidenceofckdinthemalmodietandcancerstudy
AT petermnilsson geneticpredispositionforrenaldysfunctionandincidenceofckdinthemalmodietandcancerstudy
AT ollemelander geneticpredispositionforrenaldysfunctionandincidenceofckdinthemalmodietandcancerstudy
AT marjuorhomelander geneticpredispositionforrenaldysfunctionandincidenceofckdinthemalmodietandcancerstudy
_version_ 1725867050403889152